HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins
HIV entry is a highly specific and time-sensitive process that can be divided into receptor binding, coreceptor binding, and membrane fusion. Bifunctional antiviral proteins (bAVPs) exploit the multi-step nature of the HIV entry process by binding to two different extracellular targets. They are gen...
Main Authors: | Alexander Falkenhagen, Sadhna Joshi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-12-01
|
Series: | Molecular Therapy: Nucleic Acids |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253118302427 |
Similar Items
-
Further Characterization of the Bifunctional HIV Entry Inhibitor sCD4-FIT45
by: Alexander Falkenhagen, et al.
Published: (2017-06-01) -
The Antiviral Compound PSP Inhibits HIV-1 Entry via PKR-Dependent Activation in Monocytic Cells
by: Eduardo Alvarez-Rivera, et al.
Published: (2023-03-01) -
Bifunctional Ligands for Inhibition of Tight-Binding Protein-Protein Interactions.
by: Ivan, T, et al.
Published: (2016) -
HIV Entry and Its Inhibition: How Do Chemokines Fit In?
by: Hartley Oliver
Published: (2005-12-01) -
Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry
by: Wenjiao Wu, et al.
Published: (2015-12-01)